Man shot Sunday morning on Arlington Avenue has life-threatening injuries
St. Paul police are investigating a shooting that occurred Sunday morning in which the victim has life-threatening injuries.
Officers were called to the 100 block of Arlington Avenue West just after 11 a.m. to investigate shots fired, according to Alyssa Arcand, a St. Paul police spokeswoman.
When officers arrived, they found a crashed vehicle with blood around it and evidence there had been a shooting.
Soon after, a man arrived at Regions Hospital with gunshot wounds. His injuries are life-threatening, Arcand said.
The investigation was continuing on Sunday afternoon and no arrests had been made.
Related Articles
Skywatch: Get a stellar start to your day
St. Paul woman charged in fatal Maplewood hit-and-run
Minnesota crime numbers continue to drop, according to BCA report
St. Paul murder victim’s son completes Trades Academy with local cop’s help
St. Paul woman arrested in fatal Maplewood hit-and-run, held pending murder charge
More Stories
Meta and TikTok fail to halt thousands of social media addiction lawsuits
A US appeals court has rejected a challenge by Meta and TikTok, allowing wider litigation against major platforms to proceed...
Harrods returns to £84.9m profit after Al Fayed compensation payouts
Harrods returned to a pre-tax profit of £84.9 million in the year to the end of January, according to its...
Beyoncé buys out LVMH’s stake in SirDavis whisky brand
Beyoncé has acquired full control of SirDavis, the American whisky brand she established two years ago with LVMH, after the...
87% of parents want entrepreneurial skills taught in schools
More than a third of British parents (35 per cent) would rather their child start a business than go to...
Cambridge Aerospace valued at $3.4bn after raising $300m
Defence technology company Cambridge Aerospace has raised $300 million at a valuation of $3.4 billion, two years after it was...
Rare disease investment rises after US voucher renewal, UK lags
Investment in rare disease biotechs has increased since the US Food and Drug Administration’s Rare Pediatric Disease Priority Review Voucher...
